AstraZeneca TV spot for at-home FluMist lands in FDA crosshairs as DTC ad crackdown ramps up

16th September 2025 Uncategorised 0

Last week, on the same day the Trump administration laid out its plan to rein in direct-to-consumer drug advertising, the FDA sent out its first untitled letter in months, this one taking issue with a commercial for AstraZeneca’s self-administered FluMist influenza vaccine.

More: AstraZeneca TV spot for at-home FluMist lands in FDA crosshairs as DTC ad crackdown ramps up
Source: fierce